150 related articles for article (PubMed ID: 12205068)
1. Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
J Antimicrob Chemother; 2002 Sep; 50(3):411-20. PubMed ID: 12205068
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro activities of ABT-773 against aerobic and anaerobic pathogens isolated from skin and soft-tissue animal and human bite wound infections.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
Antimicrob Agents Chemother; 2000 Sep; 44(9):2525-9. PubMed ID: 10952607
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activity of ertapenem and 11 other antimicrobial agents against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell K; Fernandez H
J Antimicrob Chemother; 2001 Nov; 48(5):641-51. PubMed ID: 11679553
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.
Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
Antimicrob Agents Chemother; 1997 Jul; 41(7):1552-7. PubMed ID: 9210683
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez H
Antimicrob Agents Chemother; 2002 Mar; 46(3):866-70. PubMed ID: 11850275
[TBL] [Abstract][Full Text] [Related]
6. Activities of HMR 3004 (RU 64004) and HMR 3647 (RU 66647) compared to those of erythromycin, azithromycin, clarithromycin, roxithromycin, and eight other antimicrobial agents against unusual aerobic and anaerobic human and animal bite pathogens isolated from skin and soft tissue infections in humans.
Goldstein EJ; Citron DM; Hunt Gerardo S; Hudspeth M; Merriam CV
Antimicrob Agents Chemother; 1998 May; 42(5):1127-32. PubMed ID: 9593139
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of gemifloxacin compared to seven other oral antimicrobial agents against aerobic and anaerobic pathogens isolated from antral sinus puncture specimens from patients with sinusitis.
Goldstein EJ; Conrads G; Citron DM; Merriam CV; Warren Y; Tyrrell K
Diagn Microbiol Infect Dis; 2002 Feb; 42(2):113-8. PubMed ID: 11858906
[TBL] [Abstract][Full Text] [Related]
8. Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K
Antimicrob Agents Chemother; 2000 Oct; 44(10):2747-51. PubMed ID: 10991855
[TBL] [Abstract][Full Text] [Related]
9. Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.
Goldstein EJ; Citron DM; Hudspeth M; Hunt Gerardo S; Merriam CV
J Antimicrob Chemother; 1998 Mar; 41(3):391-6. PubMed ID: 9578167
[TBL] [Abstract][Full Text] [Related]
10. Activity of gatifloxacin compared to those of five other quinolones versus aerobic and anaerobic isolates from skin and soft tissue samples of human and animal bite wound infections.
Goldstein EJ; Citron DM; Merriam CV; Tyrrell K; Warren Y
Antimicrob Agents Chemother; 1999 Jun; 43(6):1475-9. PubMed ID: 10348774
[TBL] [Abstract][Full Text] [Related]
11. Faropenem, a new oral penem: antibacterial activity against selected anaerobic and fastidious periodontal isolates.
Milazzo I; Blandino G; Caccamo F; Musumeci R; Nicoletti G; Speciale A
J Antimicrob Chemother; 2003 Mar; 51(3):721-5. PubMed ID: 12615878
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activities of azithromycin, Bay y 3118, levofloxacin, sparfloxacin, and 11 other oral antimicrobial agents against 194 aerobic and anaerobic bite wound isolates.
Goldstein EJ; Nesbit CA; Citron DM
Antimicrob Agents Chemother; 1995 May; 39(5):1097-100. PubMed ID: 7625795
[TBL] [Abstract][Full Text] [Related]
13. Linezolid activity compared to those of selected macrolides and other agents against aerobic and anaerobic pathogens isolated from soft tissue bite infections in humans.
Goldstein EJ; Citron DM; Merriam CV
Antimicrob Agents Chemother; 1999 Jun; 43(6):1469-74. PubMed ID: 10348773
[TBL] [Abstract][Full Text] [Related]
14. Role of anaerobic bacteria in bite-wound infections.
Goldstein EJ; Citron DM; Finegold SM
Rev Infect Dis; 1984; 6 Suppl 1():S177-83. PubMed ID: 6372026
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of telithromycin and 10 oral agents against aerobic and anaerobic pathogens isolated from antral puncture specimens from patients with sinusitis.
Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrel KL; Fernandez H
Antimicrob Agents Chemother; 2003 Jun; 47(6):1963-7. PubMed ID: 12760875
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
Pelak BA; Citron DM; Motyl M; Goldstein EJ; Woods GL; Teppler H
J Antimicrob Chemother; 2002 Nov; 50(5):735-41. PubMed ID: 12407133
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
[TBL] [Abstract][Full Text] [Related]
18. Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group.
Talan DA; Citron DM; Abrahamian FM; Moran GJ; Goldstein EJ
N Engl J Med; 1999 Jan; 340(2):85-92. PubMed ID: 9887159
[TBL] [Abstract][Full Text] [Related]
19. Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agents.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1993 May; 37(5):1150-3. PubMed ID: 8390810
[TBL] [Abstract][Full Text] [Related]
20. Chapter 2-5-3b. Anaerobic infections (individual fields): skin and soft tissue infections--bite infections.
;
J Infect Chemother; 2011 Jul; 17 Suppl 1():77-9. PubMed ID: 21728097
[No Abstract] [Full Text] [Related]
[Next] [New Search]
